» Articles » PMID: 18805087

Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2008 Sep 23
PMID 18805087
Citations 524
Authors
Affiliations
Soon will be listed here.
Abstract

Dysregulation of lipid metabolism in individual tissues leads to systemic disruption of insulin action and glucose metabolism. Utilizing quantitative lipidomic analyses and mice deficient in adipose tissue lipid chaperones aP2 and mal1, we explored how metabolic alterations in adipose tissue are linked to whole-body metabolism through lipid signals. A robust increase in de novo lipogenesis rendered the adipose tissue of these mice resistant to the deleterious effects of dietary lipid exposure. Systemic lipid profiling also led to identification of C16:1n7-palmitoleate as an adipose tissue-derived lipid hormone that strongly stimulates muscle insulin action and suppresses hepatosteatosis. Our data reveal a lipid-mediated endocrine network and demonstrate that adipose tissue uses lipokines such as C16:1n7-palmitoleate to communicate with distant organs and regulate systemic metabolic homeostasis.

Citing Articles

Impact of Olive Oil Components on the Expression of Genes Related to Type 2 Diabetes Mellitus.

Munteanu C, Kotova P, Schwartz B Nutrients. 2025; 17(3).

PMID: 39940428 PMC: 11820997. DOI: 10.3390/nu17030570.


The secretory function of adipose tissues in metabolic regulation.

Liu Y, Qian S, Tang Y, Tang Q Life Metab. 2025; 3(2):loae003.

PMID: 39872218 PMC: 11748999. DOI: 10.1093/lifemeta/loae003.


Cell Labeling with 15-YNE Is Useful for Tracking Protein Palmitoylation and Metabolic Lipid Flux in the Same Sample.

Merz N, Schilling K, Thomas D, Hahnefeld L, Grosch S Molecules. 2025; 30(2).

PMID: 39860245 PMC: 11767944. DOI: 10.3390/molecules30020377.


FABP4 as a therapeutic host target controlling SARS-CoV-2 infection.

Baazim H, Koyuncu E, Tuncman G, Burak M, Merkel L, Bahour N EMBO Mol Med. 2025; 17(3):414-440.

PMID: 39843629 PMC: 11904229. DOI: 10.1038/s44321-024-00188-x.


Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective.

Wang Z, Zhu H, Xiong W Front Med. 2025; .

PMID: 39821730 DOI: 10.1007/s11684-024-1116-0.


References
1.
Furuhashi M, Hotamisligil G . Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008; 7(6):489-503. PMC: 2821027. DOI: 10.1038/nrd2589. View

2.
Furuhashi M, Tuncman G, Gorgun C, Makowski L, Atsumi G, Vaillancourt E . Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007; 447(7147):959-65. PMC: 4076119. DOI: 10.1038/nature05844. View

3.
Paillard F, Catheline D, Le Duff F, Bouriel M, Deugnier Y, Pouchard M . Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis. 2007; 18(6):436-40. DOI: 10.1016/j.numecd.2007.02.017. View

4.
Moraes R, Blondet A, Birkenkamp-Demtroeder K, Tirard J, Orntoft T, Gertler A . Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology. 2003; 144(11):4773-82. DOI: 10.1210/en.2003-0456. View

5.
Ntambi J, Miyazaki M . Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res. 2003; 43(2):91-104. DOI: 10.1016/s0163-7827(03)00039-0. View